Caricamento...
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to decrease with longer duration of oral contraceptive use. Although the effects of using oral contraceptives in the general population are well established (approximately 50% risk reduction in ovarian cancer), the e...
Salvato in:
| Pubblicato in: | Am J Obstet Gynecol |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278569/ https://ncbi.nlm.nih.gov/pubmed/33493488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2021.01.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|